Trial Profile
Efficacy of IPX066 for Japanese Parkinson's disease patients. Open trial
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 04 Jun 2019
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 03 Jun 2019 Status changed from not yet recruiting to discontinued.
- 24 May 2016 New trial record